Search

everythinglearnresearchcommunity

for

Search:↓

SHBG may be a useful early indicator and treatment target for PCOS.

Androgens play a complex role in skin conditions like acne and hair loss in women, and normal blood levels don't always show true androgen status.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Hormones might affect the skin condition hidradenitis suppurativa, but their exact role is unclear.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Young women with diffuse hair loss may have low SHBG levels, which could lead to more active testosterone and contribute to their hair loss.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

The review found no clear link between vitamin D receptor gene variations and polycystic ovary syndrome.

Prolactin may affect hair growth differently based on gender and scalp area.

DHT's role in hair loss is important, but measuring its level for diagnosis is questionable.

Iron deficiency is not a significant cause of hair loss in women.

Recent genetic insights show that low-renin hypertension includes a range from essential hypertension to secondary or familial forms, affecting diagnosis and treatment.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Women with excessive male-pattern hair growth should get a full hormone check-up to find and treat any underlying issues, considering both medical and emotional aspects.

Many women with PCOS have undiagnosed health issues and show different symptoms based on the clinic they visit.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Vegetarian Indian women with PCOS have higher inflammation levels than non-vegetarians.

Certain SHBG gene variants, like rs727428, are linked to higher testosterone levels in women with PCOS.

Hair loss in men and women is linked to high stress hormone levels and other hormonal imbalances, suggesting treatments should be customized to each person's hormones.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

More research is needed to determine if iron deficiency causes hair loss.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

Systemic retinoids are effective for psoriasis but have side effects; benefits may outweigh risks, especially when reducing cancer risks from other treatments.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.